Morpho Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Masaki Hiraga

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	20.4yrs
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	6.3yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Masaki Hiraga (50 yo)

20.4yrs

Amtszeit

Mr. Masaki Hiraga serves as President & Chairman of Board of Morpho, Inc.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Masaki Hiraga	President & Chairman of Board	20.4yrs	keine Daten	keine Daten
Takayuki Nishiyama	Senior Director & GM of Product Development Department	5.8yrs	keine Daten	0.053% ¥ 4.4m
Yoto Nagata	Independent Outside Director	3.8yrs	keine Daten	keine Daten
Masato Uehara	Audit & Supervisory Board Member	17.8yrs	keine Daten	0.12% ¥ 9.8m
Shigeo Kagami	Independent Outside Director	7.8yrs	keine Daten	keine Daten
Hidetada Negishi	Member of Audit & Supervisory Board	6.8yrs	keine Daten	0.0078% ¥ 650.4k
Yukari Akiyama	Independent Outside Director	1.8yrs	keine Daten	keine Daten
Tetsuri Kurozumi	Audit & Supervisory Board Member	less than a year	keine Daten	keine Daten

6.3yrs

Durchschnittliche Betriebszugehörigkeit

55.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 3653Die Vorstandsmitglieder gelten als erfahren (5.8 Jahre durchschnittliche Amtszeit).

Morpho Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Morpho, Inc., Annual General Meeting, Jan 30, 2024

Less than half of directors are independent

Less than half of directors are independent

Morpho, Inc., Annual General Meeting, Jan 29, 2021

Recent updates

Here's What's Concerning About Morpho's (TSE:3653) Returns On Capital

New major risk - Financial data availability

Investors Give Morpho, Inc. (TSE:3653) Shares A 28% Hiding

Investor sentiment deteriorates as stock falls 27%

Impressive Earnings May Not Tell The Whole Story For Morpho (TSE:3653)

New major risk - Share price stability

Second quarter 2024 earnings released: EPS: JP¥39.76 (vs JP¥22.23 loss in 2Q 2023)

We're Not Very Worried About Morpho's (TSE:3653) Cash Burn Rate

Morpho, Inc. to Report Fiscal Year 2024 Results on Dec 13, 2024

First quarter 2024 earnings released: JP¥16.77 loss per share (vs JP¥47.38 loss in 1Q 2023)

Investor Optimism Abounds Morpho, Inc. (TSE:3653) But Growth Is Lacking

Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)

Morpho, Inc. to Report Q3, 2024 Results on Sep 13, 2024

Morpho, Inc., Annual General Meeting, Jan 30, 2024

Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)

New minor risk - Share price stability

Third quarter 2023 earnings released: JP¥15.60 loss per share (vs JP¥34.51 loss in 3Q 2022)

Second quarter 2023 earnings released: JP¥22.23 loss per share (vs JP¥15.99 loss in 2Q 2022)

First quarter 2023 earnings released: JP¥47.38 loss per share (vs JP¥42.54 loss in 1Q 2022)

Morpho, Inc.’s SoftNeuro Enables 19x Faster Inference of 3D Simulation on Fugaku

Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)

Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)

Less than half of directors are independent

Morpho, Inc. to Report Q2, 2023 Results on Jun 09, 2023

Third quarter 2022 earnings released: JP¥34.51 loss per share (vs JP¥43.42 loss in 3Q 2021)

Second quarter 2022 earnings released: JP¥15.99 loss per share (vs JP¥21.26 loss in 2Q 2021)

Less than half of directors are independent

Morpho, Inc. to Report Fiscal Year 2022 Results on Dec 09, 2022

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Morpho, Inc. (TSE:3653) announces an Equity Buyback for 300,000 shares, representing 5.54% for ¥360 million.

Second quarter 2021 earnings released: JP¥21.26 loss per share (vs JP¥10.77 profit in 2Q 2020)

First quarter 2021 earnings released: JP¥45.94 loss per share (vs JP¥9.10 loss in 1Q 2020)

Morpho, Inc. to Report Fiscal Year 2021 Results on Dec 10, 2021

Morpho, Inc. to Report Q2, 2021 Results on Jun 11, 2021

Full year 2020 earnings released: JP¥121 loss per share (vs JP¥62.97 profit in FY 2019)

Morpho, Inc. to Report Q1, 2021 Results on Mar 12, 2021

New 90-day low: JP¥1,371

Full year 2020 earnings released: JP¥121 loss per share

Morpho, Inc., Annual General Meeting, Jan 29, 2021

Morpho, Inc.(TSE:3653) dropped from S&P Global BMI Index

Morpho, Inc. to Report Q3, 2020 Results on Sep 11, 2020

Geschäftsführer

Amtszeit

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter